| نویسندگان | Sedigheh Abdollahi |
| نشریه | Scientific Reports |
| شماره صفحات | 45556-45574 |
| شماره سریال | 1 |
| شماره مجلد | 15 |
| ضریب تاثیر (IF) | 4.259 |
| نوع مقاله | Full Paper |
| تاریخ انتشار | 2025 |
| نوع نشریه | چاپی |
| کشور محل چاپ | ایران |
| نمایه نشریه | ISI،JCR،isc،Scopus |
| کلید واژه ها | Molecular dynamics, Radiopharmaceutical nanocarriers, Brachytherapy, Technetium, 99m, Carbon nanotubes, Targeted drug delivery, Metadynamics |
|---|
چکیده مقاله
Radiolabeled nanocarriers that can simultaneously deliver therapeutic and diagnostic agents are promising for targeted cancer therapy. In this study, we employed molecular dynamics and metadynamics simulations to investigate how the chemical identity of drug molecules influences the behavior of technetium-99 m (⁹⁹ᵐTc)-loaded carbon nanotube (CNT) nanocarriers at the atomic scale. Four clinically relevant drugs—methotrexate, diclofenac, ketotifen, and piroxicam—were conjugated to a single-walled CNT (SWCNT) via a bifunctional chelating group. Our results revealed that drug structure significantly affects radionuclide binding strength, molecular diffusion, and membrane affinity. The methotrexate-functionalized nanocarrier exhibited the most stable technetium coordination (− 825.80 kJ/mol), the lowest diffusion coefficient (0.0070 × 10⁻⁵ cm²/s), and the strongest interaction with a model phospholipid membrane (− 1376.02 kJ/mol). Free energy landscapes reconstructed from metadynamics simulations further confirmed the high thermodynamic stability of this configuration. These findings suggest that rational drug selection can effectively tune the physicochemical behavior of CNT-based radiopharmaceuticals, providing a mechanistic foundation for designing multifunctional nanocarriers with improved performance for nuclear imaging and site-specific drug delivery.
لینک ثابت مقاله